Current trends in the treatment of recurrent adenocystic cancer of the salivary glands: case report

Salivary gland carcinomas is a rare family of neoplasms with different histological characteristics and biological behavior. Treatment regimens have remained virtually unchanged for decades, leaving the leading role for surgical treatment and radiation therapy. However, a special place in the saliva...

Full description

Saved in:
Bibliographic Details
Main Authors: O. A. Saprina, M. A. Kropotov, S. A. Tulyandin, K. A. Ganina, N. A. Kozlov, B. B. Vizigina
Format: Article
Language:Russian
Published: ABV-press 2023-03-01
Series:Опухоли головы и шеи
Subjects:
Online Access:https://ogsh.abvpress.ru/jour/article/view/850
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849241606781140992
author O. A. Saprina
M. A. Kropotov
S. A. Tulyandin
K. A. Ganina
N. A. Kozlov
B. B. Vizigina
author_facet O. A. Saprina
M. A. Kropotov
S. A. Tulyandin
K. A. Ganina
N. A. Kozlov
B. B. Vizigina
author_sort O. A. Saprina
collection DOAJ
description Salivary gland carcinomas is a rare family of neoplasms with different histological characteristics and biological behavior. Treatment regimens have remained virtually unchanged for decades, leaving the leading role for surgical treatment and radiation therapy. However, a special place in the salivary gland carcinomas group is occupied by adenoid cystic carcinoma, which is quite often characterized by a recurrent and / or metastatic course with the use of chemotherapy as the main option in treatment. It is worth noting the fact that the results of standard chemotherapy regimens show unsatisfactory results, respectively, with recurrent or metastatic adenoid cystic carcinoma, treatment options are minimal. Accordingly, there is a need to study new therapeutic methods for the treatment of this disease. In this situation, high hopes were placed on targeted therapy, in particular, the family of epidermal growth factor receptors, c-Kit are the most frequently studied molecular targets. Due to the rare occurrence of adenoid cystic carcinoma, the number of cases of using targeted therapy for analysis is relatively small, so each clinical observation is of particular value. The following is a clinical case of treatment of recurrent adenoid cystic carcinoma using a personalized treatment approach.Aim. To describe the clinical observation of the use of targeted drugs in recurrent or metastatic adenocystic cancer of the salivary glands.
format Article
id doaj-art-04bab0023b0348cfa4c716ba92d3c7c1
institution Kabale University
issn 2222-1468
2411-4634
language Russian
publishDate 2023-03-01
publisher ABV-press
record_format Article
series Опухоли головы и шеи
spelling doaj-art-04bab0023b0348cfa4c716ba92d3c7c12025-08-20T04:00:07ZrusABV-pressОпухоли головы и шеи2222-14682411-46342023-03-0112410911510.17650/2222-1468-2022-12-4-109-115530Current trends in the treatment of recurrent adenocystic cancer of the salivary glands: case reportO. A. Saprina0M. A. Kropotov1S. A. Tulyandin2K. A. Ganina3N. A. Kozlov4B. B. Vizigina5N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaN. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaN. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaN. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaN. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaN. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaSalivary gland carcinomas is a rare family of neoplasms with different histological characteristics and biological behavior. Treatment regimens have remained virtually unchanged for decades, leaving the leading role for surgical treatment and radiation therapy. However, a special place in the salivary gland carcinomas group is occupied by adenoid cystic carcinoma, which is quite often characterized by a recurrent and / or metastatic course with the use of chemotherapy as the main option in treatment. It is worth noting the fact that the results of standard chemotherapy regimens show unsatisfactory results, respectively, with recurrent or metastatic adenoid cystic carcinoma, treatment options are minimal. Accordingly, there is a need to study new therapeutic methods for the treatment of this disease. In this situation, high hopes were placed on targeted therapy, in particular, the family of epidermal growth factor receptors, c-Kit are the most frequently studied molecular targets. Due to the rare occurrence of adenoid cystic carcinoma, the number of cases of using targeted therapy for analysis is relatively small, so each clinical observation is of particular value. The following is a clinical case of treatment of recurrent adenoid cystic carcinoma using a personalized treatment approach.Aim. To describe the clinical observation of the use of targeted drugs in recurrent or metastatic adenocystic cancer of the salivary glands.https://ogsh.abvpress.ru/jour/article/view/850salivary gland cancertargeted therapyimatinibtyrosine kinase inhibitorsadenoid cystic carcinoma
spellingShingle O. A. Saprina
M. A. Kropotov
S. A. Tulyandin
K. A. Ganina
N. A. Kozlov
B. B. Vizigina
Current trends in the treatment of recurrent adenocystic cancer of the salivary glands: case report
Опухоли головы и шеи
salivary gland cancer
targeted therapy
imatinib
tyrosine kinase inhibitors
adenoid cystic carcinoma
title Current trends in the treatment of recurrent adenocystic cancer of the salivary glands: case report
title_full Current trends in the treatment of recurrent adenocystic cancer of the salivary glands: case report
title_fullStr Current trends in the treatment of recurrent adenocystic cancer of the salivary glands: case report
title_full_unstemmed Current trends in the treatment of recurrent adenocystic cancer of the salivary glands: case report
title_short Current trends in the treatment of recurrent adenocystic cancer of the salivary glands: case report
title_sort current trends in the treatment of recurrent adenocystic cancer of the salivary glands case report
topic salivary gland cancer
targeted therapy
imatinib
tyrosine kinase inhibitors
adenoid cystic carcinoma
url https://ogsh.abvpress.ru/jour/article/view/850
work_keys_str_mv AT oasaprina currenttrendsinthetreatmentofrecurrentadenocysticcancerofthesalivaryglandscasereport
AT makropotov currenttrendsinthetreatmentofrecurrentadenocysticcancerofthesalivaryglandscasereport
AT satulyandin currenttrendsinthetreatmentofrecurrentadenocysticcancerofthesalivaryglandscasereport
AT kaganina currenttrendsinthetreatmentofrecurrentadenocysticcancerofthesalivaryglandscasereport
AT nakozlov currenttrendsinthetreatmentofrecurrentadenocysticcancerofthesalivaryglandscasereport
AT bbvizigina currenttrendsinthetreatmentofrecurrentadenocysticcancerofthesalivaryglandscasereport